View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOJ/DEA RIN: 1117-AB64 Publication ID: Spring 2023 
Title: Transfer of Prescription Information Between Pharmacies for Initial Filling of Electronic Prescriptions for Schedules II-V Controlled Substances 
Abstract:

DEA is proposing to revise its regulations to specify the procedure for transferring unfilled electronic prescriptions for controlled substances from one DEA registered retail pharmacy to another DEA registered retail pharmacy.  This rule will address the requirements governing the transfer of unfilled electronic prescriptions.

 
Agency: Department of Justice(DOJ)  Priority: Substantive, Nonsignificant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 1306   
Legal Authority: 21 U.S.C. 821, 829, 871(b)   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  11/19/2021  86 FR 64881   
NPRM Comment Period End  01/18/2022 
Final Action  06/00/2023 
Additional Information: DEA docket number 637
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: Businesses  Federalism: No 
Included in the Regulatory Plan: No 
RIN Information URL: DPW@dea.gov   Public Comment URL: www.regulations.gov  
RIN Data Printed in the FR: No 
Agency Contact:
Scott A. Brinks
Section Chief, Regulatory Drafting and Support Section, Diversion Control Division
Department of Justice
Drug Enforcement Administration
8701 Morrissette Drive,
Springfield, VA 22152
Phone:571 362-8209
Email: scott.a.brinks@dea.gov